June 27, 2025 -- The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for...
Vous n'êtes pas connecté
A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumours more efficiently. Thanks to a recent study published in Molecular Therapy – Methods & Clinical Development from Dan Cappabianca and Krishanu Saha at the Wisconsin Institute for Discovery, Chimeric Antigen Receptor (CAR) T-cell therapy can be [...]
June 27, 2025 -- The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for...
European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation in the European Union (EU) for Zemcelpro...
In vivo CAR T cell generation is a pioneering immunotherapy approach that reprograms the immune system to fight cancer and autoimmune diseases.
Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...
Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...
In today's world, diet is crucial for health. Certain foods can lower cancer risk. Broccoli has sulforaphane, which helps destroy bad cells....
In today's world, diet is crucial for health. Certain foods can lower cancer risk. Broccoli has sulforaphane, which helps destroy bad cells....
The development of a novel approach to generate CAR T cells in vivo using targeted lipid nanoparticles represents a significant breakthrough in...
Researchers from The University of Osaka find that a protein expressed on malaria-infected red blood cells both hides it from the immune system and...
According to recent research data, most Americans remain unaware of CAR T-cell therapy, which represents a revolutionary medlinkcancer/medlink...